1577-P: Recruitment of Spanish-Speaking Families into a Behavioral Intervention Trial

Introduction and Objective: Behavioral research in pediatric type 1 diabetes (T1D) typically requires English fluency. Research materials are often available only in English, limiting participation of Spanish-speaking individuals. Enrolling Spanish-speaking families broadens the reach and relevance of T1D research. We describe our recruitment process and progress with Spanish-speaking families in a T1D intervention trial. Methods: We reviewed the first 9 months of recruitment of Spanish-speaking families in an ongoing trial for youth ages 10-13 with T1D and parents. Recruitment metrics include number of families invited to participate, reached and confirmed eligible, consented, completed baseline data, and randomized. Preparation for recruitment of Spanish-speaking families included expert consultation, professional and in-house committee-based translation of materials, and recruitment script adaptations based on initial efforts. Results: Current recruitment metrics are presented in the Figure. Anecdotally, engagement of Spanish-speaking families has been well-received yet has required more contact attempts, family rapport-building, longer consent calls, and greater technological support for remote consent procedures. Conclusion: To enhance recruitment and retention of Spanish-speaking families, the study team will establish a Spanish Community Advisory Board to guide implementation of community-informed and responsive engagement strategies. Disclosure B. Duran: None. Y. Rojas: None. G. Maya: None. S. White: None. W.L. Levy: None. D. DeSalvo: Consultant; Current; Dexcom, Inc., Insulet Corporation. Advisory Panel; Current; Sanofi. Research Support; Current; Medtronic. S. Majidi: Advisory Panel; Current; Sanofi. R. Streisand: None. M. Hilliard: None. Funding National Institute of Diabetes and Digestive and Kidney Disease, 1R01DK131350, 3R01DK131350-03S1, 1K26DK138332, 1K26DK138330